Alclometasone dipropionate | Aclovate | anti-inflammatory | CAS#66734-13-2

MedKoo Cat#: 317163 | Name: Alclometasone dipropionate

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Alclometasone is synthetic glucocorticoid steroid for topical use in dermatology as anti-inflammatory, antipruritic, antiallergic, antiproliferative and vasoconstrictive agent. The prodrug alclometasone dipropionate is marketed as Aclovate by GlaxoSmithKline.

Chemical Structure

Alclometasone dipropionate

CAS#66734-13-2

Theoretical Analysis

MedKoo Cat#: 317163

Name: Alclometasone dipropionate

CAS#: 66734-13-2

Chemical Formula: C28H37ClO7

Exact Mass: 520.2228

Molecular Weight: 521.05

Elemental Analysis: C, 64.54; H, 7.16; Cl, 6.80; O, 21.49

Price and Availability

Size	Price	Availability	Quantity
10mg	USD 350.00	2 Weeks
25mg	USD 650.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

Aclovate; Alclometasone dipropionate; Almeta; Delonal; Sch 22219; Vaderm.

IUPAC/Chemical Name

(7R,9S,10R,11S,13S,14S,16R,17R)-7-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(propionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate

InChi Key

DJHCCTTVDRAMEH-DUUJBDRPSA-N

InChi Code

InChI=1S/C28H37ClO7/c1-6-22(33)35-14-21(32)28(36-23(34)7-2)15(3)10-18-24-19(29)12-16-11-17(30)8-9-26(16,4)25(24)20(31)13-27(18,28)5/h8-9,11,15,18-20,24-25,31H,6-7,10,12-14H2,1-5H3/t15-,18+,19-,20+,24-,25+,26+,27+,28+/m1/s1

SMILES Code

CCC(=O)OCC(=O)[C@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2[C@@H](CC4=CC(=O)C=C[C@]34C)Cl)O)C)C)OC(=O)CC

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO, not in water

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 521.05 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501285/ PubMed PMID: 30000344. 2: Sun Y, Narayan VA, Wittenberg GM. Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disorders. BMC Pharmacol Toxicol. 2016 Oct 21;17(1):47. PubMed PMID: 27765060; PubMed Central PMCID: PMC5073882. 3: Lacouture ME, Keefe DM, Sonis S, Jatoi A, Gernhardt D, Wang T, Doherty JP, Giri N, Nadanaciva S, O'Connell J, Sbar E, Piperdi B, Garon EB. A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer. Ann Oncol. 2016 Sep;27(9):1712-8. doi: 10.1093/annonc/mdw227. Epub 2016 Jun 10. PubMed PMID: 27287210. 4: Ulff E, Maroti M, Serup J, Falkmer U. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams. Radiother Oncol. 2013 Aug;108(2):287-92. doi: 10.1016/j.radonc.2013.05.033. Epub 2013 Jul 2. PubMed PMID: 23827771. 5: Zimmerman B, Chamlin SL. A 12-year-old boy with foot lesions. Pediatr Ann. 2013 Jan;42(1):11-2. doi: 10.3928/00904481-20121221-12. PubMed PMID: 23316825. 6: Yamamoto Y, Fukami T, Koide T, Suzuki T, Hiyama Y, Tomono K. Pharmaceutical evaluation of steroidal ointments by ATR-IR chemical imaging: distribution of active and inactive pharmaceutical ingredients. Int J Pharm. 2012 Apr 15;426(1-2):54-60. doi: 10.1016/j.ijpharm.2012.01.017. Epub 2012 Jan 20. PubMed PMID: 22286017. 7: Paller AS, Eichenfield LF, Kirsner RS, Shull T, Jaracz E, Simpson EL; US Tacrolimus Ointment Study Group. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. Pediatrics. 2008 Dec;122(6):e1210-8. doi: 10.1542/peds.2008-1343. Epub 2008 Nov 17. PubMed PMID: 19015204. 8: Isaksson M. Corticosteroid contact allergy--the importance of late readings and testing with corticosteroids used by the patients. Contact Dermatitis. 2007 Jan;56(1):56-7. PubMed PMID: 17177720. 9: Nakagawa H. Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan. Clin Drug Investig. 2006;26(5):235-46. Review. PubMed PMID: 17163257. 10: Boyd AS. Localized chronic cutaneous lupus erythematosus masquerading as pigmented lesions: a new clinical subset? Lupus. 2006;15(5):292-5. PubMed PMID: 16761504. 11: Ujiie H, Shimizu T, Shimizu H. Cutaneous reactions to imatinib mesylate treated by topical steroid. Am J Hematol. 2005 Mar;78(3):246. PubMed PMID: 15726597. 12: Ciconte A, Mills AE, Shipley A, Marks R. Subacute cutaneous lupus erythematosus presenting in a child. Australas J Dermatol. 2002 Feb;43(1):62-4. PubMed PMID: 11869212. 13: Brazzini B, Pimpinelli N. New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. Am J Clin Dermatol. 2002;3(1):47-58. Review. PubMed PMID: 11817968. 14: Sakuma S, Higashi Y, Sato N, Sasakawa T, Sengoku T, Ohkubo Y, Amaya T, Goto T. Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids). Int Immunopharmacol. 2001 Jun;1(6):1219-26. PubMed PMID: 11407316. 15: Iwakiri K, Hata M, Miura Y, Numano K, Yuge M, Sasaki E. Allergic contact dermatitis due to bendazac and alclometasone dipropionate. Contact Dermatitis. 1999 Oct;41(4):218-39. Review. PubMed PMID: 10515101. 16: Sengoku T, Morita K, Sakuma S, Motoyama Y, Goto T. Possible inhibitory mechanism of FK506 (tacrolimus hydrate) ointment for atopic dermatitis based on animal models. Eur J Pharmacol. 1999 Aug 27;379(2-3):183-9. PubMed PMID: 10497905. 17: Stitt WZ, Scott GA, Martin RE, Gaspari AA. Multiple chemical sensitivities, including iatrogenic allergic contact dermatitis, in a patient with chronic actinic dermatitis: implications for management. Am J Contact Dermat. 1996 Sep;7(3):166-70. PubMed PMID: 8957333. 18: Eubanks LE, McBurney EI, Galen W, Reed R. Linear scleroderma in children. Int J Dermatol. 1996 May;35(5):330-6. Review. PubMed PMID: 8734654. 19: Lepoittevin JP, Drieghe J, Dooms-Goossens A. Studies in patients with corticosteroid contact allergy. Understanding cross-reactivity among different steroids. Arch Dermatol. 1995 Jan;131(1):31-7. PubMed PMID: 7826093. 20: Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol. 1992 Jul;27(1):29-34. PubMed PMID: 1619073.

View History

Ald-CH2-PEG3-azide